PALB2, CHEK2 and ATM rare variants and cancer risk: Data from COGS

Melissa C. Southey, David E. Goldgar, Robert Winqvist, Katri Pylkäs, Fergus Couch, Marc Tischkowitz, William D. Foulkes, Joe Dennis, Kyriaki Michailidou, Elizabeth J. van Rensburg, Tuomas Heikkinen, Heli Nevanlinna, John L. Hopper, Thilo Dörk, Kathleen B M Claes, Jorge Reis-Filho, Zhi Ling Teo, Paolo Radice, Irene Catucci, Paolo PeterlongoHelen Tsimiklis, Fabrice A. Odefrey, James G. Dowty, Marjanka K. Schmidt, Annegien Broeks, Frans B. Hogervorst, Senno Verhoef, Jane Carpenter, Christine Clarke, Rodney J. Scott, Peter A. Fasching, Lothar Haeberle, Arif B. Ekici, Matthias W. Beckmann, Julian Peto, Isabel dos-Santos-Silva, Olivia Fletcher, Nichola Johnson, Manjeet K. Bolla, Elinor J. Sawyer, Ian Tomlinson, Michael J. Kerin, Nicola Miller, Federik Marme, Barbara Burwinkel, Rongxi Yang, Pascal Guénel, Bernard Peissel, Bernardo Bonanni, Loris Bernard, kConFab Investigators, Australian Ovarian Cancer Study Group

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'PALB2, CHEK2 and ATM rare variants and cancer risk: Data from COGS'. Together they form a unique fingerprint.

Medicine & Life Sciences